Literature DB >> 3867663

Rate of cholesteryl ester transfer between high and low density lipoproteins in human serum and a case with decreased transfer rate in association with hyperalphalipoproteinemia.

T Kurasawa, S Yokoyama, Y Miyake, T Yamamura, A Yamamoto.   

Abstract

The rate of cholesteryl ester transfer between intrinsic high and low density lipoproteins (HDL and LDL) was measured in human serum in the absence of lecithin:cholesterol acyltransferase (LCAT) and very low density lipoproteins. The rate was calculated according to the equilibrium transfer model between the two lipoprotein cholesteryl ester pools. The average rate of the transfer was 213 +/- 95 nmol/h/ml (mean +/- S.E.) for all 20 normal and 13 hyperlipoproteinemic subjects. The transfer rate in individual serum was higher by several times than the cholesterol esterification rate, showing that cholesteryl ester generated by LCAT on HDL is promptly distributed among various lipoprotein subclasses. The rate of cholesteryl ester transfer in the serum was significantly proportional to the product of intrinsic HDL and LDL concentrations, a possible indicator of the frequency of collision between these lipoproteins, for the range of physiological lipoprotein concentrations. Among the subjects analyzed was a patient with remarkable hyperalphalipoproteinemia accompanied by hypertriglyceridemia, who showed a very low rate of cholesteryl ester transfer in relation to his LDL and HDL concentrations. Compositional analysis of lipoprotein lipids of the patients also supported the possibility of impaired neutral lipids transfer activity among lipoproteins in the blood.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3867663     DOI: 10.1093/oxfordjournals.jbchem.a135418

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  14 in total

Review 1.  Genetic basis of lipoprotein disorders.

Authors:  J L Breslow
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

2.  Association testing by DNA pooling: an effective initial screen.

Authors:  Aruna Bansal; Dirk van den Boom; Stefan Kammerer; Christiane Honisch; Gail Adam; Charles R Cantor; Patrick Kleyn; Andi Braun
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-10       Impact factor: 11.205

Review 3.  miRNAs and High-Density Lipoprotein metabolism.

Authors:  Ángel Baldán; Thomas Q de Aguiar Vallim
Journal:  Biochim Biophys Acta       Date:  2016-02-09

4.  Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia.

Authors:  A von Eckardstein; H Holz; M Sandkamp; W Weng; H Funke; G Assmann
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

5.  Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins.

Authors:  E Quinet; A Tall; R Ramakrishnan; L Rudel
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

Review 6.  Beyond statins: new lipid lowering strategies to reduce cardiovascular risk.

Authors:  Davide Noto; Angelo B Cefalù; Maurizio R Averna
Journal:  Curr Atheroscler Rep       Date:  2014-06       Impact factor: 5.113

7.  Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency.

Authors:  K Ikewaki; D J Rader; T Sakamoto; M Nishiwaki; N Wakimoto; J R Schaefer; T Ishikawa; T Fairwell; L A Zech; H Nakamura
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

8.  A hyperalphalipoproteinaemic family with normal cholesteryl ester transfer/exchange activity.

Authors:  J E Groener; P G da Col; G M Kostner
Journal:  Biochem J       Date:  1987-02-15       Impact factor: 3.857

Review 9.  Apolipoprotein genes and atherosclerosis.

Authors:  J L Breslow
Journal:  Clin Investig       Date:  1992-05

10.  Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency.

Authors:  K Ikewaki; M Nishiwaki; T Sakamoto; T Ishikawa; T Fairwell; L A Zech; M Nagano; H Nakamura; H B Brewer; D J Rader
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.